Ramsay Health Care suspends dividend and raises capital

Ramsay Health Care Limited (ASX: RHC) shares are in a trading halt after the company announced a capital raising.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Australia's largest hospital operator Ramsay Health Care Limited (ASX: RHC) were placed in a trading halt earlier today, pending details of a capital raising.

Capital raising and dividend suspension

Ramsay is looking to undertake an equity raising worth up to $1.4 billion, consisting of $1.2 billion in an underwritten institutional placement of shares and $200 million in a non-underwritten share purchase plan.

The institutional placement will be conducted at $56.00, representing a 12.9% discount from Ramsay's last closing price of $64.29 and will see approximately 21.4 million new shares being issued. Following the completion of the placement, Ramsay will be looking to raise up to $200 million from retail shareholders through a share purchase plan.

In addition to the capital raising, Ramsay announced that due to the impact of the coronavirus pandemic on cash flow, the company has temporarily suspended payment of its ordinary share dividends. However, Ramsay did note that it will continue to pay dividends on its Convertible Adjustable Rate Equity Securities (CARES).

Why is Ramsay raising capital?

In an announcement to the market this morning, Ramsay cited that the suspension of elective procedures due to COVID-19 has led to an uncertain operating environment. As a result, the equity raising will provide Ramsay with financial flexibility and security in the current environment, whilst also allowing the company to take advantage of any future growth opportunities.

Ramsay has operations in more than 500 locations across 11 countries. As a result of the coronavirus pandemic, respective governments in each of Ramsay's major operating regions deferred elective procedures in private hospitals in order to support public health systems.

Last month, Ramsay withdrew its earnings guidance for FY20, citing the uncertain duration and impact of the coronavirus pandemic. With elective surgeries being the main source of revenue for private operators like Ramsay, the Australian government recently provided private hospitals with a $1.3 billion viability guarantee. However, with some elective surgeries being resumed, the income that private hospitals receive will reduce the funding flow from the government.

Should you buy?

Restrictions on elective and non-urgent surgeries will be partially lifted by the federal government on 27 April. As a result, post-cancer, hip, knee, and other joint replacement surgeries will be able to go ahead in addition to IVF procedures.

The Ramsay share price has tanked more than 20% from its high in mid-February of $80.93. Ramsay shares will remain in a trading halt until the commencement of normal trading on Thursday, 24 April 2020.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Up 427% this year, why today is a big day for Mesoblast shares

Why is everyone talking about Mesoblast shares on Friday?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Is this beaten-down ASX healthcare share a bargain buy now?

One expert has given their view on this stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »